Characteristics of <it>pncA </it>mutations in multidrug-resistant tuberculosis in Taiwan
<p>Abstract</p> <p>Background</p> <p>Pyrazinamide (PZA) is an important first-line drug in multidrug-resistant tuberculosis (MDRTB) treatment. However, the unreliable results obtained from traditional susceptibility testing limits its usefulness in clinical settings. The detection of <it>pncA </it>g...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2011-09-01
|
| Colección: | BMC Infectious Diseases |
| Acceso en línea: | http://www.biomedcentral.com/1471-2334/11/240 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
